I haven't watched the webinar yet, will do so ASAP. However with regard to Jon 'being more vocal' about NEU doing P3 trials alone, and 'not necessarily talking to big pharma', it reminds me of another stock I hold (in the gold development space) where the boss is constantly talking about being ready and able to move into production without any help/mergers/ TOs etc..
I reckon it's all bluff in both cases. It's simply presenting a front of confidence and strength (we don't need you, we are ready, willing and able to do it ourselves), rather than weakness (it will be expensive, we don't have the experience, lots of unknowns etc etc). It's the right approach to take IMO.
JP is playing a straight bat as our captain, and I love his work, but I've commented before that I reckon he'd make a good card player too.
GLA, hope you've got more spare $ than I did to hoover up a few parcels today!
NEU Price at posting:
$16.00 Sentiment: Buy Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)